Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C22H22N2O4S |
| Molecular Weight | 410.486 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CC1=CC=C(C=C1S(=O)(=O)N2CCCCC2)C(=O)OC3=C4N=CC=CC4=CC=C3
InChI
InChIKey=WORIMYADZQJWOU-UHFFFAOYSA-N
InChI=1S/C22H22N2O4S/c1-16-10-11-18(15-20(16)29(26,27)24-13-3-2-4-14-24)22(25)28-19-9-5-7-17-8-6-12-23-21(17)19/h5-12,15H,2-4,13-14H2,1H3
| Molecular Formula | C22H22N2O4S |
| Molecular Weight | 410.486 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 10:19:35 GMT 2023
by
admin
on
Sat Dec 16 10:19:35 GMT 2023
|
| Record UNII |
55Q8B94HS5
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
WIKIPEDIA |
Designer-drugs-QMPSB
Created by
admin on Sat Dec 16 10:19:35 GMT 2023 , Edited by admin on Sat Dec 16 10:19:35 GMT 2023
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
3929482
Created by
admin on Sat Dec 16 10:19:35 GMT 2023 , Edited by admin on Sat Dec 16 10:19:35 GMT 2023
|
PRIMARY | |||
|
QMPSB
Created by
admin on Sat Dec 16 10:19:35 GMT 2023 , Edited by admin on Sat Dec 16 10:19:35 GMT 2023
|
PRIMARY | QMPSB is an arylsulfonamide-based synthetic cannabinoid that has been sold as a designer drug. QMPSB was first discovered by Lambeng and colleagues in 2007. It acts as a full agonist of the CB1 receptor and CB2 receptor with Ki values of 3 nM and 4 nM, respectively. A large number of related derivatives were subsequently produced, with the main focus of this work being to increase selectivity for the non-psychoactive CB2 receptor. This work led on from an earlier series of sulfamoyl benzamide derivatives for which a patent was filed in 2004. The quinolin-8-yl ester motif of QMPSB led to the discovery of other designer cannabinoids such as PB-22 and BB-22. | ||
|
312606-87-4
Created by
admin on Sat Dec 16 10:19:35 GMT 2023 , Edited by admin on Sat Dec 16 10:19:35 GMT 2023
|
PRIMARY | |||
|
QMPSB
Created by
admin on Sat Dec 16 10:19:35 GMT 2023 , Edited by admin on Sat Dec 16 10:19:35 GMT 2023
|
PRIMARY | The identification and structural elucidation of the novel synthetic cannabimimetic 8-quinolinyl 4-methyl-3-(1-piperidinylsulfonyl)benzoate (QMPSB) by GC-MS, LC-MS and NMR is reported. QMPSB was identified in Queensland, Australia on plant material packaged as herbal incense. The identification of QMPSB was initially hampered due to trans-esterification occurring in the extraction solvent. An investigation of the trans-esterification of QMPSB in methanol and ethanol was conducted and analytical data for the respective methyl and ethyl esters are reported. | ||
|
55Q8B94HS5
Created by
admin on Sat Dec 16 10:19:35 GMT 2023 , Edited by admin on Sat Dec 16 10:19:35 GMT 2023
|
PRIMARY | |||
|
DTXSID901045939
Created by
admin on Sat Dec 16 10:19:35 GMT 2023 , Edited by admin on Sat Dec 16 10:19:35 GMT 2023
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
